About Moderna
Moderna (NASDAQ:MRNA) is a biotechnology company focused on drug discovery and drug development, especially known for its mRNA technology, which was crucial in developing one of the first COVID-19 vaccines. This breakthrough has propelled Moderna into the spotlight, showcasing its potential in harnessing mRNA technology for vaccines against infectious diseases, oncology, and other therapeutic areas. With an objective to create a new generation of transformative medicines for patients worldwide, Moderna is dedicated to advancing the science of mRNA while expanding its portfolio through ongoing projects in various stages of development. The company works tirelessly on innovation to address unmet medical needs, aiming for significant impacts on global health through its groundbreaking research.
Snapshot
Operations
Products and/or services of Moderna
- mRNA-1273, a COVID-19 vaccine designed to protect against SARS-CoV-2.
- mRNA technology platform used for developing vaccines for infectious diseases like Zika, Epstein-Barr, and cytomegalovirus.
- Personalized cancer vaccine (mRNA-4157) targeting multiple neoantigens for melanoma in combination with pembrolizumab.
- mRNA-1345, a vaccine candidate against Respiratory Syncytial Virus (RSV) for older adults and children.
- Therapeutic programs targeting rare diseases using mRNA technology to express therapeutic proteins.
- mRNA-based flu vaccine candidates, aiming to offer broader protection than traditional flu vaccines.
Moderna executive team
- Mr. Stéphane BancelCEO & Director
- Dr. Stephen Hoge M.D.President
- Mr. James M. MockChief Financial Officer
- Ms. Shannon Thyme Klinger J.D.Chief Legal Officer & Corporate Secretary
- Dr. Jerh Collins Ph.D.Chief Technical Operations & Quality Officer
- Ms. Lavina Talukdar CFASenior VP & Head of Investor Relations
- Ms. Tracey FranklinChief People & Digital Technology Officer
- Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D.Chief Development Officer
- Mr. Dave JohnsonChief Data & AI Officer
- Dr. Charbel Haber M.P.H., Ph.D.Senior VP & Head of Global Regulatory Science